Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation

被引:182
作者
Kim, KI
Giannakopoulos, NV
Virgin, HW
Zhang, DE
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[3] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA
关键词
D O I
10.1128/MCB.24.21.9592-9600.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein ISGylation is unique among ubiquitin-like conjugation systems in that the expression and conjugation processes are induced by specific stimuli, mainly via the alpha/beta interferon signaling pathway. It has been suggested that protein ISGylation plays a special role in the immune response, because of its interferonsignal dependency and its appearance only in higher eukaryotic organisms. Here, we report the identification of an ISG15-conjugating enzyme, Ubc8. Like other components of the protein ISGylation system (ISG15, UBE1L, and UBP43), Ubc8 is an interferon-inducible protein. Ubc8 clearly mediates protein ISGylation in transfection assays. The reduction of Ubc8 expression by small interfering RNA causes a decrease in protein ISGylation in HeLa cells upon interferon treatment. Neither UbcH7/UbcM4, the closest homologue of Ubc8 among known ubiquitin E2s, nor the small ubiquitin-like modifier E2 Ubc9 supports protein ISGylation. These findings strongly suggest that Ubc8 is a major ISG15-conjugating enzyme responsible for protein ISGylation upon interferon stimulation. Furthermore, we established an assay system to detect ISGylated target proteins by cotransfection of ISG15, UBE1L, and Ubc8 together with a target protein to be analyzed. This method provides an easy and effective way to identify new targets for the ISGylation system and will facilitate related studies.
引用
收藏
页码:9592 / 9600
页数:9
相关论文
共 60 条
[1]   Molecular determinants of resistance to antiandrogen therapy [J].
Chen, CD ;
Welsbie, DS ;
Tran, C ;
Baek, SH ;
Chen, R ;
Vessella, R ;
Rosenfeld, MG ;
Sawyers, CL .
NATURE MEDICINE, 2004, 10 (01) :33-39
[2]   Staring, a novel E3 ubiquitin-protein ligase that targets syntaxin 1for degradation [J].
Chin, LS ;
Vavalle, JP ;
Li, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35071-35079
[3]   Deubiquitinating enzymes: Their diversity and emerging roles [J].
Chung, CH ;
Baek, SH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (03) :633-640
[4]   Deubiquitinating enzymes: A new class of biological regulators [J].
D'Andrea, A ;
Pellman, D .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 33 (05) :337-352
[5]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[6]   Immunoregulatory properties of ISG15, an interferon-induced cytokine [J].
DCunha, J ;
Knight, E ;
Haas, AL ;
Truitt, RL ;
Borden, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :211-215
[7]  
DCunha J, 1996, J IMMUNOL, V157, P4100
[8]   Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays [J].
Der, SD ;
Zhou, AM ;
Williams, BRG ;
Silverman, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15623-15628
[9]   Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].
Durbin, JE ;
Hackenmiller, R ;
Simon, MC ;
Levy, DE .
CELL, 1996, 84 (03) :443-450
[10]   ACCUMULATION OF AN MESSENGER-RNA AND PROTEIN IN INTERFERON-TREATED EHRLICH ASCITES TUMOR-CELLS [J].
FARRELL, PJ ;
BROEZE, RJ ;
LENGYEL, P .
NATURE, 1979, 279 (5713) :523-525